Biotechnology
Technology
Health

Aeterna Zentaris

$4.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (1.43%) Today
-$0.07 (-1.64%) After Hours

Why Robinhood?

You can buy or sell AEZS and other stocks, options, ETFs, and crypto commission-free!

About

Aeterna Zentaris Inc. Common Stock, also called Aeterna Zentaris, is engaged in developing and commercializing novel treatments in oncology, endocrinology and women's health. Read More It operates through biopharmaceutical segment. AEterna Zentaris was founded on September 12, 1990 and is headquartered in Charleston, SC.

Employees
34
Headquarters
Charleston, South Carolina
Founded
1990
Market Cap
69.22M
Price-Earnings Ratio
7.89
Dividend Yield
0.00
Average Volume
309.49K
High Today
$4.33
Low Today
$4.16
Open Price
$4.23
Volume
116.56K
52 Week High
$4.39
52 Week Low
$1.12

Collections

Biotechnology
Technology
Health
Biopharmaceutical
Pharmaceutical
US
North America

News

Yahoo FinanceMar 19

Aeterna Zentaris to Announce Fourth Quarter and Year End 2018 Financial and Operating Results on March 26, 2019

CHARLESTON, S.C., March 19, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (AEZS) (AEZS) will announce its fourth quarter and year ended December 31, 2018 financial and operating results after market close on Tuesday, March 26, 2019. About Aeterna Zentaris Inc. Aeterna Zentaris Inc. is a specialty biopharmaceutical company focused on commercializing novel pharmaceutical therapies, principally through out-licensing arrangements. Aeterna Zentaris is a party to a license and assignment agreement with a sub...

132
Yahoo FinanceMar 18

Aeterna Zentaris (AEZS) Moves to Buy: Rationale Behind the Upgrade

Aeterna Zentaris (AEZS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).

129
Markets InsiderMar 13

IIROC Trade Resumption - AEZS

TORONTO, March 13, 2019 /CNW/ - Trading resumes in: Company: AEterna Zentaris Inc. TSX Symbol: AEZS (all issues) Resumption (ET): 8:00 AM IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada. SOURCE Investment Industry R...

187

Earnings

-$0.61
-$0.12
$0.38
$0.87
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$0.19 per share
Actual
Available Mar 26, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.